Chinese Herbal Injections for Primary Nephrotic Syndrome in Adults: A Systematic Review and Network Meta-Analysis

Table 4

SUCRA of Chinese herbal injections for primary nephrotic syndrome.

	Complete remission	Total remission	Serum albumin	Triglycerides	Serum creatinine	Adverse reactions
WM	0.20 (43)	1.70 (43)	0.00 (49)	9.00 (36)	15.0 (23)	53.3 (18)
CXQ + WM	39.0 (4)	37.8 (4)	25.4 (6)	77.8 (5)	51.5 (6)	20.3 (3)
DS + WM	43.2 (9)	46.4 (9)	23.9 (11)	43.4 (9)	80.6 (5)	33.9 (3)
DSCX + WM	36.2 (3)	36.5 (3)	36.5 (4)	22.0 (2)	43.7 (2)	61.7 (2)
DH + WM	82.9 (6)	68.6 (6)	81.9 (4)	43.5 (2)	38.4 (2)	53.1 (1)
DZH + WM	56.6 (4)	82.1 (4)	41.3 (4)	54.2 (5)	73.8 (4)	71.3 (3)
FFDS + WM	24.6 (6)	22.2 (6)	50.2 (7)	63.2 (4)	31.3 (6)	54.9 (3)
HQ + WM	46.7 (15)	54.0 (15)	60.9 (21)	36.9 (12)	80.5 (3)	56.8 (3)
SK + WM	64.9 (6)	70.1 (6)	84.8 (6)	67.1 (2)	53.8 (3)	28.9 (3)
SXT + WM	84.1 (3)	83.0 (3)	85.5 (5)	79.1 (5)	41.6 (2)	33.6 (3)
YXY + WM	71.7 (1)	46.5 (1)	59.7 (3)	27.4 (2)	23.8 (3)	81.1 (3)
XST + WM	—	—	49.9 (3)	76.3 (1)	66.0 (1)	51.1 (1)

Data are shown as SUCRA (number of studies). SUCRA = surface under the cumulative ranking curve, WM = Western medicine, CXQ = Chuanxiongqin injection, DS = Danshen injection, DSCX = Danshenchuanxiongqin injection, DH = Danhong injection, DZH = Dengzhanhua injection, FFDS = Fufangdanshen injection, HQ = Huangqi injection, SK = Shenkang injection, SXT = Shuxuetong injection, YXY = Yinxingye injection, and XST = Xueshuantong injection.